Patents by Inventor Marc Avondet

Marc Avondet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140287433
    Abstract: This invention relates to a method of determining presence, amount and/or activity of a clostridial neurotoxin in a sample, the method comprising or consisting of the following steps: (a) bringing said sample into contact with a liposome, said liposome comprising (aa) at least one receptor on its outer surface, said receptor being capable of binding said neurotoxin and comprising or consisting of (i) a glycolipid and (ii) a peptide or protein; and (ab) a substrate in its interior, said substrate (i) being cleavable by the peptidase comprised in said neurotoxin and (ii) generating a detectable signal upon cleavage, said detectable signal preferably being generated by (1) the donor of a FRET pair, said donor exhibiting increased fluorescence upon cleavage by said peptidase, (2) a luminescent compound formed upon said cleavage, or (3) an enzyme formed upon said cleavage; and (b) determining whether an increase in signal occurs as compared to the absence of said sample, wherein such increase is indicative of the
    Type: Application
    Filed: July 18, 2012
    Publication date: September 25, 2014
    Applicants: ETH ZÜRICH, VERTEIDIGUNG, BEVÖLKERUNGSSCHUTZ UND SPORT, TOXOGEN GMBH, MIPROLAB GMBH
    Inventors: Oliver Weingart, Marc Avondet, Martin Loessner, Andreas Rummel, Frank Gessler